What's Happening?
A new collection of research articles is being compiled to explore gene therapy as a treatment for cardiac and vascular diseases. This initiative aims to target molecular mechanisms responsible for myocardial dysfunction and vascular pathologies. The
collection will include studies on gene editing and silencing techniques that promote angiogenesis and improve cardiomyocyte function. Researchers are encouraged to submit work that addresses the limitations of current therapies and advances in precision gene delivery.
Why It's Important?
Gene therapy represents a promising frontier in treating cardiac and vascular diseases, which are leading causes of mortality worldwide. By focusing on molecular mechanisms, this research could lead to more effective treatments that address the root causes of these conditions. The potential to improve heart health and vascular function through gene therapy could significantly impact public health, reducing the burden of cardiovascular diseases and associated healthcare costs.
